skip to main content


May 31, 2016

Janssen Inc. v. Teva Canada Limited

Featuring: Stephanie Anderson, Peter Wilcox and Marian Wolanski

We successfully represented Janssen in this action for damages resulting from infringement of the patent covering Janssen’s LEVAQUIN product. Following a two week trial, the Federal Court agreed that Janssen’s U.S. affiliate had standing to sue for patent infringement and awarded damages in excess of $18 Million. Teva appealed on every issue. The Court of Appeal affirmed (2018 FCA 33).


  • Patents

© 2015 Belmore Neidrauer LLP | Legal Disclaimer | Privacy Policy